Stella Lee
Otolaryngology · Pittsburgh, PANPI 1851573893
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (43.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Sanofi at 50.5% of the total. Among otolaryngology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 234 payments — averaging $1869.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$221K
- Sanofi-aventis U.S. LLC$70K
- AstraZeneca$49K
- Regeneron Healthcare Solutions, Inc.$34K
- GSK$26K
- Regeneron$13K
- plus $24K from 10 others
Across 154 payments — averaging $2944.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$284K
- GSK$44K
- Sanofi US Services Inc.$34K
- Sanofi$27K
- F. Hoffmann-la Roche AG$24K
- Optinose US, Inc.$21K
- plus $19K from 4 others
What the payments were for
- Consulting fees$191,48744%
- Speaking & faculty fees$150,67334%
- Travel & lodging$91,49421%
- Food & beverage$3,8531%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 92 | $220,927 |
| Sanofi-aventis U.S. LLC | 17 | $70,146 |
| AstraZeneca | 37 | $49,481 |
| Regeneron Healthcare Solutions, Inc. | 22 | $33,637 |
| GSK | 27 | $26,302 |
| Regeneron | 7 | $13,286 |
| Genentech, Inc. | 16 | $12,663 |
| Novartis Pharma AG | 2 | $4,995 |
| Insmed, Inc. | 4 | $4,897 |
| Aerin Medical Inc. | 3 | $501 |
| Integra Lifesciences Corporation | 2 | $205 |
| Optinose US, Inc. | 1 | $135 |
| Stryker | 1 | $126 |
| Acclarent, Inc | 1 | $99 |
| Medtronic | 1 | $74 |
| Davol Inc. | 1 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$321,662
- TEZSPIRE$30,498
- XOLAIR$17,411
- FASENRA$14,721
- NUCALA$11,638
- VIVAER STYLUS$501
- RHINAER STYLUS$501
- Xhance$135
- Acclarent Aera$128
- Inspira Air$128
- RELIEVA SPINPLUS NAV$128
- TruDi Probe$128
- XPRESS LOPROFILE$126
How this compares
$437,507 in reported general payments places this provider in the 95th percentile of 456 otolaryngology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 83 | $1,283 |
| Budesonide | 16 | $1,237 |
| Mometasone Furoate | 17 | $1,208 |
| Mupirocin | 132 | $972 |
| Azelastine Hcl | 31 | $951 |
| Ipratropium Bromide | 30 | $598 |
| CefuroximeCefuroxime Axetil | 21 | $186 |
| Oxycodone Hcl | 20 | $44 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Pittsburgh
- Matthew SpectorPittsburgh$56K
- Umamaheswar DuvvuriPittsburgh$48K
- Jose ZevallosPittsburgh$40K
- Thomas KaffenbergerPittsburgh$33K
- Priya KrishnaPittsburgh$20K
- Eric WangPittsburgh$15K
- Suman GollaPittsburgh$13K
- Giuseppe StaltariPittsburgh$8K
- Warren SwegalPittsburgh$7K
- Carl SnydermanPittsburgh$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.